EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Peptide-based inhibitors targeting the PD-1/PD-L1 axis: potential immunotherapeutics for cancer

Magdalena Bojko, Katarzyna Węgrzyn, Emilia Sikorska, Piotr Ciura, Claire Battin, Peter Steinberger, Katarzyna Magiera-Mularz, Grzegorz Dubin, Adam Kulesza, Adam K Sieradzan, Marta Spodzieja, Sylwia Rodziewicz-Motowidło

Translational Oncology · 2024-04 · 42 · 101892

DOI: 10.1016/j.tranon.2024.101892 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Oncology, 2024-04. Verfasst von Magdalena Bojko und 11 weiteren Autor:innen. Beteiligte Einrichtung: University of Gdańsk, Faculty of Chemistry, Wita Stwosza 63, 80-308 Gdańsk, Poland. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Narodowe Centrum Nauki, Polpharma Scientific Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

CancerDisulfide-linked peptideImmune checkpoint inhibitorImmunotherapyPD-1 - Programmed cell death 1PD-L1 - Programmed cell death 1 - ligand 1

Autor:innen und Institutionen

  • University of Gdańsk, Faculty of Chemistry, Wita Stwosza 63, 80-308 Gdańsk, Poland.
  • University of Gdańsk, Intercollegiate Faculty of Biotechnology of the University of Gdańsk and the Medical University of Gdańsk, Abrahama 58, 80-307 Gdańsk, Poland.
  • Medical University of Vienna, Institute of Immunology, Division of Immune Receptors and T cell Activation, Lazarettgasse 19, 1090 Vienna, Austria.
  • Małopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa 7A, 30-387 Kraków, Poland.
  • Jagiellonian University, Faculty of Chemistry, Gronostajowa 2, 30-387 Kraków, Poland.
  • University of Gdańsk, Faculty of Chemistry, Wita Stwosza 63, 80-308 Gdańsk, Poland. Electronic address: marta.spodzieja@ug.edu.pl.

Förderung

  • Narodowe Centrum Nauki
  • Polpharma Scientific Foundation

Zitieren

APA

Bojko, M., Węgrzyn, K., Sikorska, E., Ciura, P., Battin, C., Steinberger, P., Magiera-Mularz, K., Dubin, G., Kulesza, A., Sieradzan, A. K., Spodzieja, M., & Rodziewicz-Motowidło, S. (2024). Peptide-based inhibitors targeting the PD-1/PD-L1 axis: potential immunotherapeutics for cancer. Translational Oncology, 42, 101892. https://doi.org/10.1016/j.tranon.2024.101892

Vancouver

Bojko M, Węgrzyn K, Sikorska E, Ciura P, Battin C, Steinberger P, et al. Peptide-based inhibitors targeting the PD-1/PD-L1 axis: potential immunotherapeutics for cancer. Translational Oncology. 2024;42:101892. doi:10.1016/j.tranon.2024.101892

BibTeX
@article{Bojko2024,
  author = {Bojko, Magdalena and Węgrzyn, Katarzyna and Sikorska, Emilia and Ciura, Piotr and Battin, Claire and Steinberger, Peter and Magiera-Mularz, Katarzyna and Dubin, Grzegorz and Kulesza, Adam and Sieradzan, Adam K and Spodzieja, Marta and Rodziewicz-Motowidło, Sylwia},
  title = {Peptide-based inhibitors targeting the PD-1/PD-L1 axis: potential immunotherapeutics for cancer},
  journal = {Translational Oncology},
  year = {2024},
  volume = {42},
  pages = {101892},
  doi = {10.1016/j.tranon.2024.101892}
}
Kostenlos starten →